Prairiewood Capital, LLC Biogen Inc. Transaction History

Prairiewood Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$282.99 - $369.05 $1.39 Million - $1.82 Million	-4,920 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$259.0 - $414.71 $74,074 - $118,607	-286 Reduced 5.49%	4,920 $1.7 Million
Q1 2021 Apr 13, 2021	BUY	$242.95 - $284.63 $90,620 - $106,166	373 Added 7.72%	5,206 $1.46 Million
Q4 2020 Jan 15, 2021	BUY	$236.26 - $355.63 $1.14 Million - $1.72 Million	4,833 New	4,833 $1.18 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairiewood Capital, LLC with notifications on news.